Estados Unidos
Quiénes somos
QUILT 3.064: PD-L1 t-haNK In Subjects With Locally Advanced Or Metastatic Solid Cancers
Evaluación de la inmunogenicidad de pING-hHER3FL
NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
Una vacuna (Ad5.F35-hGCC-PADRE) para el tratamiento del adenocarcinoma gastrointestinal
Pemigatinib for the Treatment of Metastatic or Unresectable Colorectal Cancer Harboring FGFR Alterations
Safety, Tolerability, and Immunogenicity of mRNA-4157 Alone in Participants With Resected Solid Tumors and in Combination With Pembrolizumab in Participants With Unresectable Solid Tumors
Estudio para probar diferentes dosis de BI 1823911 solo y combinado con otros medicamentos en personas con diferentes tipos de cáncer avanzado con mutación KRAS.
Biweekly Intraperitoneal Oxaliplatin With Systemic Capecitabine and Bevacizumab for Patients With Peritoneal Carcinomatosis From Appendiceal or Colorectal Cancer
A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands
A Study of CC-95251, a Monoclonal Antibody Directed Against SIRPα, in Participants With Advanced Solid and Hematologic Cancers
